Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05241990
Other study ID # IRB00303116
Secondary ID P01AA029544
Status Recruiting
Phase N/A
First received
Last updated
Start date February 15, 2023
Est. completion date September 2026

Study information

Verified date March 2024
Source Johns Hopkins University
Contact JoAnna Mathena
Phone 410-955-9534
Email jmathen5@jhmi.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite availability of evidence-based alcohol reduction interventions (EBI), unhealthy alcohol use remains a barrier to HIV medication adherence, viral suppression and retention in HIV care and consequently HIV treatment as prevention (TASP). Guided by complementary implementation and evaluation frameworks-the Consolidated Framework for Implementation Research (CFIR) and RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance), The investigators will conduct a Hybrid Type 3 effectiveness-implementation evaluating implementation trial testing whether practice facilitation, an evidence-based multifaceted implementation strategy increases reach, adoption, implementation, and maintenance of stepped care for unhealthy alcohol use in three Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) HIV clinics located in Boston, San Diego, and Chapel Hill. The investigators will secondarily test whether practice facilitation is associated with decreased unhealthy alcohol use, and improved Antiretroviral Therapy (ART) adherence and viral suppression at the patient level. In practice facilitation, a practice coach will offer tools, resources, hands-on guidance, and content expertise to assist sites in offering a stepped care model of alcohol treatment to patients with unhealthy alcohol use. Stepped care will include brief intervention, cognitive behavioral therapy, and alcohol pharmacotherapy. The practice facilitation intervention will be rolled out sequentially across sites. There will be three phases at each site: pre-implementation planning, implementation with formative evaluation, and post-implementation summative evaluation. Using mixed methods, The investigators specifically propose to meet the following specific aims: (Aim 1) Tailor the practice facilitation intervention to each site using mixed methods (pre-implementation); (Aim 2a) Determine the effects of practice facilitation on implementation of stepped care (primary) and alcohol use and HIV-related outcomes (secondary) using interrupted time series analysis with synthetic controls (summative evaluation); (Aim 2b) Determine the effect of practice facilitation on reach, adoption, and maintenance of evidence-based alcohol treatment using mixed methods (formative evaluation); and (Aim 3) Describe barriers and facilitators to implementation of alcohol-related interventions at each site to describe maintenance and inform widespread sustainable implementation.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date September 2026
Est. primary completion date June 30, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Clinic Staff - Age > 18 years old - Confirmed to be clinic staff (clinical or administrative roles). - English speaking - Cognitively able to complete required survey or interview activities. Exclusion Criteria Clinic Staff - Unable to speak English Inclusion Criteria, Patients - Confirmed to be a person with HIV (PWH) receiving HIV care and participating in CNICS at one of the three clinic sites - Scoring AUDIT-C =3 for women or =4 for men, transgender women or men indicating unhealthy alcohol use. - Age = 18 years old. - English speaking. - Cognitively able to participate in stepped care for unhealthy alcohol use. Exclusion Criteria, Patients - Scoring AUDIT-C <3 for women or <4 for men or <4 for transgender women or men - Age < 18 years old - Participants cognitively unable to participate in the stepped care for unhealthy alcohol use.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Practice Facilitation
A practice coach will offer tools, resources, hands-on guidance, and content expertise to assist sites in offering a stepped care model of alcohol treatment to patients with unhealthy alcohol use.
Alcohol Stepped Care
Based on severity of alcohol use, individuals receive brief alcohol intervention delivered in person or by computer, cognitive behavioral therapy by person or computer, or pharmacotherapy for alcohol use disorder

Locations

Country Name City State
United States Fenway Community Health Boston Massachusetts
United States University of North Carolina Chapel Hill North Carolina
United States University of California, San Diego San Diego California

Sponsors (7)

Lead Sponsor Collaborator
Johns Hopkins University Fenway Community Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA), University of Alabama at Birmingham, University of California, San Diego, University of North Carolina, University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Implementation as assessed by the percent of patients receiving an alcohol intervention Percent of patients receiving an alcohol intervention since their last visit among all eligible individuals. 12 months
Secondary Change in unhealthy alcohol use as assessed by the Alcohol Use Disorder Identification test-Consumption (AUDIT-C) AUDIT-C Score of <3 in women and <4 in men indicating reduction to lower risk use Baseline and 12 months
Secondary Antiretroviral therapy adherence as assessed by a self report on a visual analog scale Self report of >90% adherence on visual analog scale with higher scores indicating greater adherence 12 months
Secondary Viral Suppression as assessed by HIV-RNA copies Viral Suppression will assessed by HIV-RNA copies. HIV-RNA <200 copies indicates viral suppression. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2